Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | ELANE | P08246 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA5A | P35218 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13727061 | 0.82 | POLB (0.50) | L3MBTL1ALDH1A1POLBKDM4EMAPT | |
| SCHEMBL26054681 | 0.82 | ELANE (0.37) | MAPK1L3MBTL1ELANEALDH1A1POLB | |
| SCHEMBL15445468 | 0.80 | ELANE (0.47) | MAPK1L3MBTL1ELANEALDH1A1KDM4E | |
| SCHEMBL7962492 | 0.80 | CES1 (0.47) | MAPK1ALDH1A1KDM4ELMNAALOX15 | |
| SCHEMBL151086 | 0.77 | FFAR1 (0.49) | L3MBTL1ALDH1A1POLBKDM4EMAPT | |
| SCHEMBL16722809 | 0.76 | ALDH1A1 (0.47) | MAPK1L3MBTL1ELANEALDH1A1KDM4E | |
| SCHEMBL6539235 | 0.76 | GAA (0.55) | POLBKMT2A | |
| SCHEMBL97165 | 0.76 | ADRA1A (0.39) | ELANEALDH1A1KMT2ALMNANPC1 | |
| SCHEMBL5058742 | 0.74 | ALDH1A1 (0.45) | MAPK1L3MBTL1ELANEALDH1A1KDM4E | |
| SCHEMBL8385 | 0.74 | ALDH1A1 (0.59) | ALDH1A1POLBKDM4EMAPTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 301 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9938312-B2 | Compounds and methods for chemical and chemo-enzymatic synthesis of complex glycans | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2018-04-10 | — | — | US | claimed |
| US-9200287-B2 | Phosphate-modified oligonucleotide analogs with enhanced immunostimulatory activity | ADIUTIDE PHARMACEUTICALS GMBH (DE) | 2015-12-01 | — | — | US | claimed |
| EP-2170353-B1 | PHOSPHATE-MODIFIED OLIGONUCLEOTIDE ANALOGS WITH IMMUNOSTIMULATORY ACTIVITY | ADIUTIDE PHARMACEUTICALS GMBH (DE) | 2015-06-03 | — | — | EP | claimed |
| US-20140051603-A1 | COMPOUNDS AND METHODS FOR CHEMICAL AND CHEMO-ENZYMATIC SYNTHESIS OF COMPLEX GLYCANS | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC (US) | 2014-02-20 | — | — | US | claimed |
| EP-2528914-A1 | FURO [3, 2 -B]PYRANE DERIVATIVES USEFUL IN THE SYNTHESIS OF HALICHONDRIN B ANALOGS | Eisai R&D Management Co., Ltd. (JP) | 2012-12-05 | — | — | EP | claimed |
| WO-2012135049-A1 | COMPOUNDS AND METHODS FOR CHEMICAL AND CHEMO-ENZYMATIC SYNTHESIS OF COMPLEX GLYCANS | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2012-10-04 | — | — | WO | claimed |
| US-20120142560-A1 | HEPARAN SULFATE SYNTHESIS | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2012-06-07 | — | — | US | claimed |
| EP-2414371-A2 | HEPARAN SULFATE SYNTHESIS | The University Of Georgia Research Foundation, Inc (US) | 2012-02-08 | — | — | EP | claimed |
| US-20110244025-A1 | MODIFIED OLIGORIBONUCLEOTIDE ANALOGS WITH ENHANCED IMMUNOSTIMULATORY ACTIVITY | ZOETIS BELGIUM SA (BE) | 2011-10-06 | — | — | US | claimed |
| WO-2011094339-A1 | FURO [3, 2 -B] PYRANE DERIVATIVES USEFUL IN THE SYNTHESIS OF HALICHONDRIN B ANALOGS | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2011-08-04 | — | — | WO | claimed |
| WO-2010117803-A2 | HEPARAN SULFATE SYNTHESIS | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2010-10-14 | — | — | WO | claimed |
| US-20100261779-A1 | Phosphate-Modified Oligonucleotide Analogs with Enhanced Immunostimulatory Activity | ADIUTIDE PHARMACEUTICALS GMBH (DE) | 2010-10-14 | — | — | US | claimed |
| US-20100144846-A1 | Oligoribonucleotides and uses thereof | COLEY PHARMACEUTICAL GMBH (DE) | 2010-06-10 | — | — | US | claimed |
| EP-2170353-A2 | PHOSPHATE-MODIFIED OLIGONUCLEOTIDE ANALOGS WITH IMMUNOSTIMULATORY ACTIVITY | Coley Pharmaceuticals GmbH (DE) | 2010-04-07 | — | — | EP | claimed |
| JP-2010507386-A | — | — | 2010-03-11 | — | — | JP | claimed |
| EP-2104738-A2 | OLIGORIBONUCLEOTIDES AND USES THEREOF | Coley Pharmaceuticals GmbH (DE) | 2009-09-30 | — | — | EP | claimed |
| WO-2008142513-A2 | PHOSPHATE-MODIFIED OLIGONUCLEOTIDE ANALOGS WITH IMMUNOSTIMULATORY ACTIVITY | COLEY PHARMACEUTICAL GMBH (DE) | 2008-11-27 | — | — | WO | claimed |
| WO-2008139262-A2 | OLIGORIBONUCLEOTIDES AND USES THEREOF | COLEY PHARMACEUTICAL GMBH (DE) | 2008-11-20 | — | — | WO | claimed |
| US-20060241076-A1 | Modified oligoribonucleotide analogs with enhanced immunostimulatory activity | COLEY PHARMACEUTICAL GMBH (DE) | 2006-10-26 | — | — | US | claimed |
| CN-116063257-A | Anticancer drug intermediate and preparation method thereof | 中国药科大学 | 2023-05-05 | — | — | CN | disclosed |
| CN-115136045-A | Optical film, polarizing plate and organic electroluminescent image display device | 柯尼卡美能达株式会社 | 2022-09-30 | — | — | CN | disclosed |
| CN-114953408-A | Method for producing obliquely stretched film | 柯尼卡美能达株式会社 | 2022-08-30 | — | — | CN | disclosed |
| CN-110832364-B | Resin composition for optical material and optical film | DIC株式会社 | 2021-10-29 | — | — | CN | disclosed |
| CN-107935949-B | Triazole compounds | 柯尼卡美能达株式会社 | 2021-05-07 | — | — | CN | disclosed |
| CN-108603961-B | Polarizing plate, method for producing polarizing plate, and liquid crystal display device | 柯尼卡美能达株式会社 | 2021-04-20 | — | — | CN | disclosed |
| CN-107533253-B | Liquid crystal display device with touch panel and manufacturing method thereof | 柯尼卡美能达株式会社 | 2021-02-02 | — | — | CN | disclosed |
| WO-2020158647-A1 | MATERIAL FOR HOT MELT EXTRUSION SYSTEM, MODELING MATERIAL FOR 3D PRINTERS, METHOD FOR PRODUCING MODELING MATERIAL FOR 3D PRINTERS, AND THREE-DIMENSIONAL MODEL | コニカミノルタ株式会社 | 2020-08-06 | — | — | WO | disclosed |
| WO-2020149206-A1 | METHOD FOR PRODUCING ACRYLIC RESIN FILM | コニカミノルタ株式会社 | 2020-07-23 | — | — | WO | disclosed |
| CN-106468798-B | Retardation film, polarizing plate, and liquid crystal display device | 柯尼卡美能达株式会社 | 2020-04-28 | — | — | CN | disclosed |
| CN-110832364-A | Resin composition for optical material and optical film | DIC株式会社 | 2020-02-21 | — | — | CN | disclosed |
| CN-107428069-B | Method for producing obliquely stretched film | 柯尼卡美能达株式会社 | 2020-01-21 | — | — | CN | disclosed |
| CN-106541566-B | Method for producing obliquely stretched film | 柯尼卡美能达株式会社 | 2020-01-17 | — | — | CN | disclosed |
| US-10351643-B2 | Polymerizable compounds, compositions, polymers, optically anisotropic articles, liquid crystal display devices and organic EL devices | DIC CORPORATION (JP) | 2019-07-16 | — | — | US | disclosed |
| US-10174132-B2 | Heparan sulfate synthesis | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2019-01-08 | — | — | US | disclosed |
| US-20180203175-A1 | TRIAZOLE COMPOUND | Konica Minolta, Inc. (JP) | 2018-07-19 | — | — | US | disclosed |
| US-10012777-B2 | Resin composition | Konica Minolta, Inc. (JP) | 2018-07-03 | — | — | US | disclosed |
| US-10005804-B2 | TC-PTP inhibitors as APC activators for immunotherapy | THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING / MCGILL UNIV (CA) | 2018-06-26 | — | — | US | disclosed |
| US-9938312-B2 | Compounds and methods for chemical and chemo-enzymatic synthesis of complex glycans | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2018-04-10 | — | — | US | disclosed |
| US-20180072763-A1 | TC-PTP INHIBITORS AS APC ACTIVATORS FOR IMMUNOTHERAPY | THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING / MCGILL UNIV (CA) | 2018-03-15 | — | — | US | disclosed |
| CN-105705498-B | Polymerizable compound, composition, polymer, optically anisotropic body, liquid crystal display element, and organic E L element | DIC株式会社 | 2018-01-30 | — | — | CN | disclosed |
| US-20170037159-A1 | POLYMERIZABLE COMPOUNDS, COMPOSITIONS, POLYMERS, OPTICALLY ANISOTROPIC ARTICLES, LIQUID CRYSTAL DISPLAY DEVICES AND ORGANIC EL DEVICES | DIC CORPORATION (JP) | 2017-02-09 | — | — | US | disclosed |
| US-9535201-B2 | Retardation film, elongated circularly polarizing plate and organic EL display produced using said retardation film | Konica Minolta, Inc. (JP) | 2017-01-03 | — | — | US | disclosed |
| US-9500790-B2 | Optical film, circularly polarizing plate, and image display device | Konica Minolta, Inc. (JP) | 2016-11-22 | — | — | US | disclosed |
| CN-105705498-A | Polymerizable compound, composition, polymer, optically anisotropic body, liquid crystal display element, and organic EL element | DIC株式会社 | 2016-06-22 | — | — | CN | disclosed |
| US-20160060365-A1 | HEPARAN SULFATE SYNTHESIS | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 2016-03-03 | — | — | US | disclosed |
| US-9221207-B2 | Method for producing long stretched film | Konica Minolta, Inc. (JP) | 2015-12-29 | — | — | US | disclosed |
| US-9200287-B2 | Phosphate-modified oligonucleotide analogs with enhanced immunostimulatory activity | ADIUTIDE PHARMACEUTICALS GMBH (DE) | 2015-12-01 | — | — | US | disclosed |
| US-20150338563-A1 | RESIN COMPOSITION, TRIAZOLE COMPOUND, OPTICAL FILM, POLARIZING PLATE, OPTICAL LENS, CIRCULARLY POLARIZING PLATE AND IMAGE DISPLAY DEVICE | KONICA MINOLTA, INC (JP) | 2015-11-26 | — | — | US | disclosed |
| EP-1861401-B1 | 7-AMINO ALKYLIDENYL-HETEROCYCLIC QUINOLONES AND NAPHTHYRIDONES | JANSSEN PHARMACEUTICA NV (BE) | 2015-11-18 | — | — | EP | disclosed |
| EP-2944676-A1 | RESIN COMPOSITION, TRIAZOLE COMPOUND, OPTICAL FILM, POLARIZING PLATE, OPTICAL LENS, CIRCULARLY POLARIZING PLATE AND IMAGE DISPLAY DEVICE | Konica Minolta, Inc. (JP) | 2015-11-18 | — | — | EP | disclosed |
| US-9186837-B2 | Method for producing long stretched film | Konica Minolta, Inc. (JP) | 2015-11-17 | — | — | US | disclosed |
| US-20150253480-A1 | RETARDATION FILM, ELONGATED CIRCULARLY POLARIZING PLATE AND ORGANIC EL DISPLAY PRODUCED USING SAID RETARDATION FILM | Konica Minolta, Inc. (JP) | 2015-09-10 | — | — | US | disclosed |
| US-20150247963-A1 | OPTICAL FILM, CIRCULARLY POLARIZING PLATE, AND IMAGE DISPLAY DEVICE | Konica Minolta, Inc. (JP) | 2015-09-03 | — | — | US | disclosed |
| CN-104769463-A | Phase difference film, circularly polarizing plate produced using the same, and organic EL display | KONICA MINOLTA INC | 2015-07-08 | — | — | CN | disclosed |
| CN-104769465-A | Phase difference film, circularly polarizing plate, and image forming device | KONICA MINOLTA INC | 2015-07-08 | — | — | CN | disclosed |
| EP-2170353-B1 | PHOSPHATE-MODIFIED OLIGONUCLEOTIDE ANALOGS WITH IMMUNOSTIMULATORY ACTIVITY | ADIUTIDE PHARMACEUTICALS GMBH (DE) | 2015-06-03 | — | — | EP | disclosed |
| US-20150114257-A1 | METHOD OF PREPARING RETARDATION FILM, POLARIZING PLATE, AND LIQUID CRYSTAL DISPLAY | Konica Minolta, Inc. (JP) | 2015-04-30 | — | — | US | disclosed |
| US-20140361456-A1 | METHOD FOR PRODUCING LONG STRETCHED FILM | Konica Minolta, Inc. (JP) | 2014-12-11 | — | — | US | disclosed |
| US-20140353872-A1 | METHOD FOR PRODUCING LONG STRETCHED FILM | Konica Minolta, Inc. (JP) | 2014-12-04 | — | — | US | disclosed |
| US-20140319508-A1 | ORGANIC ELECTROLUMINESCENT DISPLAY DEVICE | Konica Minolta, Inc. (JP) | 2014-10-30 | — | — | US | disclosed |
| US-8658261-B2 | Composition, film, polarizing plate, and liquid crystal display device | FUJIFILM CORPORATION (JP) | 2014-02-25 | — | — | US | disclosed |
| US-20140051603-A1 | COMPOUNDS AND METHODS FOR CHEMICAL AND CHEMO-ENZYMATIC SYNTHESIS OF COMPLEX GLYCANS | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC (US) | 2014-02-20 | — | — | US | disclosed |
| US-8569513-B2 | Compound having a triptycene moiety | FUJIFILM CORPORATION (JP) | 2013-10-29 | — | — | US | disclosed |
| US-8368858-B2 | Optical film, polarizing plate, and VA-mode liquid crystal display device | FUJIFILM CORPORATION (JP) | 2013-02-05 | — | — | US | disclosed |
| US-8350996-B2 | Optical compensation sheet, polarizing plate and TN-mode liquid crystal display device | FUJIFILM CORPORATION (JP) | 2013-01-08 | — | — | US | disclosed |
| EP-2528914-A1 | FURO [3, 2 -B]PYRANE DERIVATIVES USEFUL IN THE SYNTHESIS OF HALICHONDRIN B ANALOGS | Eisai R&D Management Co., Ltd. (JP) | 2012-12-05 | — | — | EP | disclosed |
| US-8313814-B2 | Cellulose acylate film, method of producing the same, cellulose derivative film, optically compensatory film using the same, optically-compensatory film incorporating polarizing plate, polarizing plate and liquid crystal display device | FUJIFILM CORPORATION (JP) | 2012-11-20 | — | — | US | disclosed |
| US-8293146-B2 | Optical film and phase difference plate, and liquid crystal compound | FUJIFILM CORPORATION (JP) | 2012-10-23 | — | — | US | disclosed |
| WO-2012135049-A1 | COMPOUNDS AND METHODS FOR CHEMICAL AND CHEMO-ENZYMATIC SYNTHESIS OF COMPLEX GLYCANS | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2012-10-04 | — | — | WO | disclosed |
| CN-102707363-A | Optical compensation sheet, polarizing plate and tn-mode liquid crystal display device | FUJIFILM CORP | 2012-10-03 | — | — | CN | disclosed |
| CN-101382615-B | Polymer film, polaroid protective film, polaroid and liquid crystal display unit | FUJI PHOTO FILM CO LTD | 2012-09-19 | — | — | CN | disclosed |
| CN-101504497-B | Liquid-crystal display device | FUJI PHOTO FILM CO LTD | 2012-09-05 | — | — | CN | disclosed |
| US-8259259-B2 | Liquid crystal display device comprising an optically anisotropic film having at least one species of liquid crystal compound which exhibits a nematic phase or a smectic phase | FUJIFILM CORPORATION (JP) | 2012-09-04 | — | — | US | disclosed |
| US-8257611-B2 | Optical film and retardation sheet, and liquid crystal compound | FUJIFILM CORPORATION (JP) | 2012-09-04 | — | — | US | disclosed |
| US-20120142560-A1 | HEPARAN SULFATE SYNTHESIS | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2012-06-07 | — | — | US | disclosed |
| US-8184247-B2 | TN-mode liquid crystal display device, optical compensatory film for use therein and method for producing optical compensatory film, and polarizing plate | FUJIFILM CORPORATION (JP) | 2012-05-22 | — | — | US | disclosed |
| US-8178601-B2 | Polymer film, polarizing plate protective film, polarizing plate and liquid crystal display device | FUJIFILM CORPORATION (JP) | 2012-05-15 | — | — | US | disclosed |
| EP-2414371-A2 | HEPARAN SULFATE SYNTHESIS | The University Of Georgia Research Foundation, Inc (US) | 2012-02-08 | — | — | EP | disclosed |
| US-8089593-B2 | Optical resin film, optical compensation sheet, polarizing plate and liquid crystal display | FUJIFILM CORPORATION (JP) | 2012-01-03 | — | — | US | disclosed |
| EP-1899763-B1 | LIQUID CRYSTAL DISPLAY DEVICE | FUJIFILM CORP (JP) | 2011-11-16 | — | — | EP | disclosed |
| WO-2011131169-A1 | VIDEO CENTERING SYSTEM HAVING VISUAL-FIELD EVALUATION AND METHOD FOR EVALUATING VISUAL FIELDS | OLLENDORF HANS-JOACHIM (DE) | 2011-10-27 | — | — | WO | disclosed |
| US-20110244025-A1 | MODIFIED OLIGORIBONUCLEOTIDE ANALOGS WITH ENHANCED IMMUNOSTIMULATORY ACTIVITY | ZOETIS BELGIUM SA (BE) | 2011-10-06 | — | — | US | disclosed |
| US-20110237804-A1 | COMPOUND HAVING A TRIPTYCENE MOIETY | FUJIFILM CORPORATION (JP) | 2011-09-29 | — | — | US | disclosed |
| US-8017199-B2 | Cellulose acylate film, process for producing cellulose acylate film, polarizing plate and liquid crystal display device | FUJIFILM CORPORATION (JP) | 2011-09-13 | — | — | US | disclosed |
| WO-2011094339-A1 | FURO [3, 2 -B] PYRANE DERIVATIVES USEFUL IN THE SYNTHESIS OF HALICHONDRIN B ANALOGS | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2011-08-04 | — | — | WO | disclosed |
| US-7989576-B2 | Triazine derivative, liquid crystal composition, anisotropic material, and liquid crystal display device using the same | FUJIFILM CORPORATION (JP) | 2011-08-02 | — | — | US | disclosed |
| US-7981488-B2 | Liquid crystal display device | FUJIFILM CORPORATION (JP) | 2011-07-19 | — | — | US | disclosed |
| US-7976914-B2 | Resin film, production method thereof, polarizing plate and liquid crystal display device | FUJIFILM CORPORATON (JP) | 2011-07-12 | — | — | US | disclosed |
| US-7951430-B2 | Cellulose acylate film, polarizing plate and liquid crystal display device | FUJIFILM CORPORATION (JP) | 2011-05-31 | — | — | US | disclosed |
| CN-101206349-B | Liquid crystal display device | FUJI PHOTO FILM CO LTD | 2011-03-30 | — | — | CN | disclosed |
| US-7888450-B2 | Liquid crystal polymer and film thereof | FUJIFILM CORPORATION (JP) | 2011-02-15 | — | — | US | disclosed |
| WO-2010117803-A2 | HEPARAN SULFATE SYNTHESIS | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2010-10-14 | — | — | WO | disclosed |
| US-20100261779-A1 | Phosphate-Modified Oligonucleotide Analogs with Enhanced Immunostimulatory Activity | ADIUTIDE PHARMACEUTICALS GMBH (DE) | 2010-10-14 | — | — | US | disclosed |
| US-20100220272-A1 | LIQUID CRYSTAL DISPLAY | FUJIFILM CORPORATION (JP) | 2010-09-02 | — | — | US | disclosed |
| US-20100157204-A1 | OPTICALLY ANISOTROPIC FILM AND LIQUID CRYSTAL DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2010-06-24 | — | — | US | disclosed |
| US-20100144846-A1 | Oligoribonucleotides and uses thereof | COLEY PHARMACEUTICAL GMBH (DE) | 2010-06-10 | — | — | US | disclosed |
| US-7732612-B2 | 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones | JANSSEN PHARMACEUTICA, N.V. (BE) | 2010-06-08 | — | — | US | disclosed |
| WO-2010056633-A2 | 7-AMINO ALKYLIDENYL-HETEROCYCLIC QUINOLONES AND NAPHTHYRIDONES | JANSSEN PHARMACEUTICA NV (BE) | 2010-05-20 | — | — | WO | disclosed |
| US-7719644-B2 | Optical compensation sheet, polarizing plate and liquid crystal display | FUJIFILM CORPORATION (JP) | 2010-05-18 | — | — | US | disclosed |
| US-7697095-B2 | Liquid crystal display device | FUJIFILM CORPORATION (JP) | 2010-04-13 | — | — | US | disclosed |
| EP-2170353-A2 | PHOSPHATE-MODIFIED OLIGONUCLEOTIDE ANALOGS WITH IMMUNOSTIMULATORY ACTIVITY | Coley Pharmaceuticals GmbH (DE) | 2010-04-07 | — | — | EP | disclosed |
| US-20100072437-A1 | COMPOSITION, COLOR FILTER AND PROCESS FOR PREPARING COLOR FILTER | FUJIFILM CORPORATION (JP) | 2010-03-25 | — | — | US | disclosed |
| US-20100066948-A1 | OPTICAL FILM, POLARIZING PLATE, AND VA-MODE LIQUID CRYSTAL DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2010-03-18 | — | — | US | disclosed |
| US-20100045901-A1 | OPTICAL FILM AND RETARDATION SHEET, AND LIQUID CRYSTAL COMPOUND | FUJIFILM CORPORATION (JP) | 2010-02-25 | — | — | US | disclosed |
| US-7667801-B2 | Liquid crystal display device | FUJIFILM CORPORATION (JP) | 2010-02-23 | — | — | US | disclosed |
| US-7651743-B2 | Cellulose acylate film, manufacturing method of cellulose acylate film, optically compensatory sheet, polarizing plate and liquid crystal display device | FUJIFILM CORPORATION (JP) | 2010-01-26 | — | — | US | disclosed |
| US-20100007828-A1 | TN-MODE LIQUID CRYSTAL DISPLAY DEVICE, OPTICAL COMPENSATORY FILM FOR USE THEREIN AND METHOD FOR PRODUCING OPTICAL COMPENSATORY FILM, AND POLARIZING PLATE | FUJIFILM CORPORATION (JP) | 2010-01-14 | — | — | US | disclosed |
| US-7645496-B2 | 1,3,5-triazine compound, composition, and optically anisotropic material composed of the same | FUJIFILM CORPORATION (JP) | 2010-01-12 | — | — | US | disclosed |
| US-20090290100-A1 | Cellulose Acylate Film, Method of Producing the Same, Cellulose Derivative Film, Optically Compensatory Film Using the Same, Optically-Compensatory Film Incorporating Polarizing Plate, Polarizing Plate and Liquid Crystal Display Device | FUJIFILM CORPORATION (JP) | 2009-11-26 | — | — | US | disclosed |
| US-7615264-B2 | Cellulose acylate film, polarizing plate, and liquid crystal display device | FUJIFILM CORPORATION (JP) | 2009-11-10 | — | — | US | disclosed |
| US-20090251650-A1 | Liquid crystal display device | FUJIFILM CORPORATION (JP) | 2009-10-08 | — | — | US | disclosed |
| EP-1652926-B1 | CRYSTALLINE EPOTHILONE D | KOSAN BIOSCIENCES INC (US) | 2009-09-30 | — | — | EP | disclosed |
| EP-2104738-A2 | OLIGORIBONUCLEOTIDES AND USES THEREOF | Coley Pharmaceuticals GmbH (DE) | 2009-09-30 | — | — | EP | disclosed |
| US-20090240022-A1 | LIQUID CRYSTAL POLYMER AND FILM THEREOF | FUJIFILM CORPORATION (JP) | 2009-09-24 | — | — | US | disclosed |
| US-20090213311-A1 | Liquid Crystal Display Device | FUJIFILM CORPORATION (JP) | 2009-08-27 | — | — | US | disclosed |
| US-20090213462-A1 | OPTICAL FILM, POLARIZATION PLATE AND IMAGE DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2009-08-27 | — | — | US | disclosed |
| US-7575696-B2 | Liquid crystal composition and anisotropic material | FUJIFILM CORPORATION (JP) | 2009-08-18 | — | — | US | disclosed |
| US-20090202748-A1 | RESIN FILM, PRODUCTION METHOD THEREOF, POLARIZING PLATE AND LIQUID CRYSTAL DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2009-08-13 | — | — | US | disclosed |
| US-20090202921-A1 | OPTICAL RECORDING COMPOSITION AND HOLOGRAPHIC RECORDING MEDIUM | FUJIFILM CORPORATION (JP) | 2009-08-13 | — | — | US | disclosed |
| CN-101504497-A | Liquid-crystal display device | FUJIFILM CORP (JP) | 2009-08-12 | — | — | CN | disclosed |
| US-20090189120-A1 | COMPOUND, LIQUID CRYSTAL COMPOSITION, AND ANISOTROPIC MATERIAL | FUJIFILM CORPORATION (JP) | 2009-07-30 | — | — | US | disclosed |
| CN-100516083-C | Glycosylated steroid derivatives with anti-migratory activity | UNIBIOSCREEN S A BRUSSELS PRIV (BE) | 2009-07-22 | — | — | CN | disclosed |
| US-20090159857-A1 | OPTICAL FILM AND PHASE DIFFERENCE PLATE, AND LIQUID CRYSTAL COMPOUND | FUJIFILM CORPORATION (JP) | 2009-06-25 | — | — | US | disclosed |
| US-20090156577-A1 | 7-AMINO ALKYLIDENYL-HETEROCYCLIC QUINOLONES AND NAPHTHYRIDONES | JANSSEN PHARMACEUTICA NV (BE) | 2009-06-18 | — | — | US | disclosed |
| US-20090153782-A1 | LIQUID CRYSTAL DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2009-06-18 | — | — | US | disclosed |
| US-20090122237-A1 | POLYMER FILM, METHOD FOR PRODUCING POLYMER FILM, OPTICAL FILM AND POLARIZING PLATE AND LIQUID CRYSTAL DISPLAY DEVICE USING THE SAME | FUJIFILM CORPORATION (JP) | 2009-05-14 | — | — | US | disclosed |
| EP-1899763-A4 | LIQUID CRYSTAL DISPLAY DEVICE | FUJIFILM CORP (JP) | 2009-05-06 | — | — | EP | disclosed |
| US-20090109379-A1 | LIQUID CRYSTAL DISPLAY DEVICE | FUJIFILM COPORATION (JP) | 2009-04-30 | — | — | US | disclosed |
| US-20090109378-A1 | COMPOSITION, FILM, POLARIZING PLATE, AND LIQUID CRYSTAL DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2009-04-30 | — | — | US | disclosed |
| CN-100480389-C | Production of polyketides | KOSAN BIOSCIENCES INC (US) | 2009-04-22 | — | — | CN | disclosed |
| US-20090085008-A1 | Cellulose compound composition and cellulose compound film | FUJIFILM CORPORATION (JP) | 2009-04-02 | — | — | US | disclosed |
| US-20090080074-A1 | POLYMER FILM, POLARIZING PLATE PROTECTIVE FILM, POLARIZING PLATE AND LIQUID CRYSTAL DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2009-03-26 | — | — | US | disclosed |
| US-20090066887-A1 | Polymer Film, Polarizing Plate Protective Film, Polarizing Plate and Liquid Crystal Display Device | FUJIFILM CORPORATION (JP) | 2009-03-12 | — | — | US | disclosed |
| CN-101382615-A | Polymer film, polaroid protective film, polaroid and liquid crystal display unit | FUJIFILM CORP (JP) | 2009-03-11 | — | — | CN | disclosed |
| US-20090051856-A1 | CELLULOSE ACYLATE FILM, POLARIZING PLATE AND LIQUID CRYSTAL DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2009-02-26 | — | — | US | disclosed |
| US-20090054658-A1 | Liquid Crystal Compound, Liquid Crystal Composition, Thin Film and Liquid Crystal Display | FUJIFILM CORPORATION (JP) | 2009-02-26 | — | — | US | disclosed |
| EP-1675852-B1 | 7-AMINO ALKYLIDENYL-HETEROCYCLIC QUINOLONES AND NAPHTHYRIDONES | JANSSEN PHARMACEUTICA NV (BE) | 2009-02-18 | — | — | EP | disclosed |
| CN-101369071-A | Optical compensation sheet, polarizing plate and tn-mode liquid crystal display device | FUJIFILM CORP (JP) | 2009-02-18 | — | — | CN | disclosed |
| US-20090033835-A1 | Optical Compensation Sheet, Polarizing Plate and Liquid Crystal Display | FUJIFILM CORPORATION (JP) | 2009-02-05 | — | — | US | disclosed |
| US-20090018305-A1 | TRIAZINE DERIVATIVE, LIQUID CRYSTAL COMPOSITION, ANISOTROPIC MATERIAL, AND LIQUID CRYSTAL DISPLAY DEVICE USING THE SAME | FUJIFILM CORPORATION (JP) | 2009-01-15 | — | — | US | disclosed |
| US-20090009866-A1 | OPTICAL COMPENSATION SHEET, POLARIZING PLATE AND TN-MODE LIQUID CRYSTAL DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2009-01-08 | — | — | US | disclosed |
| EP-1999499-A1 | POLYMER FILM, POLARIZING PLATE PROTECTIVE FILM, POLARIZING PLATE AND LIQUID CRYSTAL DISPLAY DEVICE | FUJIFILM Corporation (JP) | 2008-12-10 | — | — | EP | disclosed |
| US-7462306-B2 | Cellulose acylate film, process for producing cellulose acylate film, polarizing plate and liquid crystal display device | FUJIFILM CORPORATION (JP) | 2008-12-09 | — | — | US | disclosed |
| US-20080299329-A1 | CYCLIC OLEFIN POLYMER, OPTICAL MATERIAL, POLARIZING PLATE AND LIQUID CRYSTAL DISPLAY | FUJIFILM CORPORATION (JP) | 2008-12-04 | — | — | US | disclosed |
| WO-2008142513-A2 | PHOSPHATE-MODIFIED OLIGONUCLEOTIDE ANALOGS WITH IMMUNOSTIMULATORY ACTIVITY | COLEY PHARMACEUTICAL GMBH (DE) | 2008-11-27 | — | — | WO | disclosed |
| US-20080284957-A1 | Optical Resin Film, Optical Compensation Sheet, Polarizing Plate and Liquid Crystal Display | FUJIFILM CORPORATION (JP) | 2008-11-20 | — | — | US | disclosed |
| WO-2008139262-A2 | OLIGORIBONUCLEOTIDES AND USES THEREOF | COLEY PHARMACEUTICAL GMBH (DE) | 2008-11-20 | — | — | WO | disclosed |
| US-20080213511-A1 | Optical compensation film, process for producing optical compensation film, polarizing plate and liquid crystal display device | FUJIFILM CORPORATION (JP) | 2008-09-04 | — | — | US | disclosed |
| CN-101206349-A | Liquid crystal display device | FUJIFILM CORP (JP) | 2008-06-25 | — | — | CN | disclosed |
| WO-2008072794-A1 | OPTICAL FILM AND RETARDATION SHEET, AND LIQUID CRYSTAL COMPOUND | FUJIFILM CORPORATION (JP) | 2008-06-19 | — | — | WO | disclosed |
| US-20080137014-A1 | Liquid Crystal Display Device | FUJIFILM CORPORATION (JP) | 2008-06-12 | — | — | US | disclosed |
| EP-1924884-A1 | LIQUID CRYSTAL DISPLAY DEVICE | Fujifilm Corporation (JP) | 2008-05-28 | — | — | EP | disclosed |
| EP-1899467-A2 | MODIFIED OLIGORIBONUCLEOTIDE ANALOGS WITH ENHANCES IMMUNOSTIMULATORY ACTIVITY | Coley Pharmaceutical GmbH (DE) | 2008-03-19 | — | — | EP | disclosed |
| EP-1899763-A1 | LIQUID CRYSTAL DISPLAY DEVICE | FUJIFILM Corporation (JP) | 2008-03-19 | — | — | EP | disclosed |
| US-20080023670-A1 | LIQUID CRYSTAL COMPOSITION AND ANISOTROPIC MATERIAL | FUJIFILM CORPORATION (JP) | 2008-01-31 | — | — | US | disclosed |
| US-7323573-B2 | Production of polyketides | KOSAN BIOSCIENCES, INC. (US) | 2008-01-29 | — | — | US | disclosed |
| EP-1709063-B1 | GLYCOSYLATED STEROID DERIVATIVES WITH ANTI-MIGRATORY ACTIVITY | UNIBIOSCREEN SA (BE) | 2008-01-23 | — | — | EP | disclosed |
| US-20070298194-A1 | Cellulose Acylate Film, Process for Producing Cellulose Acylate Film, Polarizing Plate and Liquid Crystal Display Device | FUJIFILM CORPORATION (JP) | 2007-12-27 | — | — | US | disclosed |
| US-20070298192-A1 | 1,3,5-Triazine compound, composition, and optically anisotropic material composed of the same | FUJIFILM CORPORATION (JP) | 2007-12-27 | — | — | US | disclosed |
| US-20070290168-A1 | Resin film, production method thereof, polarizing plate and liquid crystal display device | FUJIFILM CORPORATION (JP) | 2007-12-20 | — | — | US | disclosed |
| US-20070281343-A9 | Recombinant Myxococcus host cells used to produce polyketides, including epothilone and epothilone analogs; agriculture, chemistry, medicinal chemistry, medicine, molecular biology, and pharmacology | ARSLANIAN ROBERT L | 2007-12-06 | — | — | US | disclosed |
| EP-1861401-A1 | 7-AMINO ALKYLIDENYL-HETEROCYCLIC QUINOLONES AND NAPHTHYRIDONES | JANSSEN PHARMACEUTICA N.V. (BE) | 2007-12-05 | — | — | EP | disclosed |
| US-7282276-B2 | Organic electroluminescent device | FUJIFILM CORPORATION (JP) | 2007-10-16 | — | — | US | disclosed |
| WO-2007111387-A1 | POLYMER FILM, POLARIZING PLATE PROTECTIVE FILM, POLARIZING PLATE AND LIQUID CRYSTAL DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2007-10-04 | — | — | WO | disclosed |
| WO-2007111388-A1 | LIQUID CRYSTAL DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2007-10-04 | — | — | WO | disclosed |
| WO-2007091716-A1 | OPTICAL FILM AND PHASE DIFFERENCE PLATE, AND LIQUID CRYSTAL COMPOUND | FUJIFILM CORPORATION (JP) | 2007-08-16 | — | — | WO | disclosed |
| CN-1997642-A | 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones | JANSSEN PHARMACEUTICA NV (BE) | 2007-07-11 | — | — | CN | disclosed |
| US-20070123473-A1 | Glycosylated steroid derivatives with anti-migratory activity | UNIBIOSCREEN S.A. (BE) | 2007-05-31 | — | — | US | disclosed |
| WO-2007061139-A1 | CELLULOSE ACYLATE FILM, METHOD OF PRODUCING THE SAME, CELLULOSE DERIVATIVE FILM, OPTICALLY COMPENSATORY FILM USING THE SAME, OPTICALLY-COMPENSATORY FILM INCORPORATING POLARIZING PLATE, POLARIZING PLATE AND LIQUID CRYSTAL DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2007-05-31 | — | — | WO | disclosed |
| US-20070111952-A1 | Glycosylated triketide delta lactones | UNIVERSITE CATHOLIQUE DE LOUVAIN (BE) | 2007-05-17 | — | — | US | disclosed |
| WO-2007052838-A1 | POLYMER FILM, METHOD FOR PRODUCING POLYMER FILM, OPTICAL FILM AND POLARIZING PLATE AND LIQUID CRYSTAL DISPLAY DEVICE USING THE SAME | FUJIFILM CORPORATION (JP) | 2007-05-10 | — | — | WO | disclosed |
| WO-2007049779-A1 | CELLULOSE COMPOUND COMPOSITION AND CELLULOSE COMPOUND FILM | FUJIFILM CORPORATION (JP) | 2007-05-03 | — | — | WO | disclosed |
| US-20070092954-A1 | Production of polyketides | ARSLANIAN ROBERT L | 2007-04-26 | — | — | US | disclosed |
| US-20070077373-A1 | Polymer film and polarizing plate and liquid crystal display device using the same | FUJI PHOTO FILM CO., LTD. (JP) | 2007-04-05 | — | — | US | disclosed |
| WO-2007023990-A1 | LIQUID CRYSTAL DISPLAY DEVICE | FUJI FILM CORPORATION (JP) | 2007-03-01 | — | — | WO | disclosed |
| US-7179805-B2 | 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones | JANSSEN PHARMACEUTICA N.V. (BE) | 2007-02-20 | — | — | US | disclosed |
| US-7176235-B2 | Epothilone derivatives and methods for making and using the same | KOSAN BIOSCIENCES, INC. (US) | 2007-02-13 | — | — | US | disclosed |
| WO-2007011003-A1 | LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION, THIN FILM AND LIQUID CRYSTAL DISPLAY | FUJIFILM CORPORATION (JP) | 2007-01-25 | — | — | WO | disclosed |
| CN-1894271-A | Glycosylated steroid derivatives with anti-migratory activity | UNIBIOSCREEN SA (BE) | 2007-01-10 | — | — | CN | disclosed |
| US-20060286313-A1 | Cellulose acylate film, manufacturing method of cellulose acylate film, optically compensatory sheet, polarizing plate and liquid crystal display device | FUJI PHOTO FILM CO., LTD. (JP) | 2006-12-21 | — | — | US | disclosed |
| WO-2006132404-A1 | LIQUID CRYSTAL DISPLAY DEVICE | FUJI FILM CORPORATION (JP) | 2006-12-14 | — | — | WO | disclosed |
| US-20060275560-A1 | Cellulose acylate film, polarizing plate, and liquid crystal display device | FUJI PHOTO FILM CO., LTD. (JP) | 2006-12-07 | — | — | US | disclosed |
| EP-1572715-B1 | STEROID COMPOUNDS WITH ANTI-TUMOR ACTIVITY | UNIBIOSCREEN SA (BE) | 2006-11-22 | — | — | EP | disclosed |
| WO-2006116458-A2 | MODIFIED OLIGORIBONUCLEOTIDE ANALOGS WITH ENHANCES IMMUNOSTIMULATORY ACTIVITY | COLEY PHARMACEUTICAL GMBH (DE) | 2006-11-02 | — | — | WO | disclosed |
| US-20060241076-A1 | Modified oligoribonucleotide analogs with enhanced immunostimulatory activity | COLEY PHARMACEUTICAL GMBH (DE) | 2006-10-26 | — | — | US | disclosed |
| US-20060240285-A1 | Organic electroluminescent device | FUJI PHOTO FILM CO., LTD. (JP) | 2006-10-26 | — | — | US | disclosed |
| EP-1709063-A2 | GLYCOSYLATED STEROID DERIVATIVES WITH ANTI-MIGRATORY ACTIVITY | Unibioscreen S.A. (BE) | 2006-10-11 | — | — | EP | disclosed |
| WO-2006101603-A1 | 7-AMINO ALKYLIDENYL-HETEROCYCLIC QUINOLONES AND NAPHTHYRIDONES | JANSSEN PHARMACEUTICA, N.V. (BE) | 2006-09-28 | — | — | WO | disclosed |
| WO-2006098162-A1 | OPTICAL COMPENSATION SHEET, POLARIZING PLATE AND LIQUID CRYSTAL DISPLAY | FUJIFILM CORPORATION (JP) | 2006-09-21 | — | — | WO | disclosed |
| WO-2006098517-A1 | OPTICAL RESIN FILM, OPTICAL COMPENSATION SHEET, POLARIZING PLATE AND LIQUID CRYSTAL DISPLAY | FUJIFILM CORPORATION (JP) | 2006-09-21 | — | — | WO | disclosed |
| WO-2006093346-A1 | CELLULOSE ACYLATE FILM, POLARIZING PLATE AND LIQUID CRYSTAL DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2006-09-08 | — | — | WO | disclosed |
| EP-1697392-A1 | GLYCOSYLATED TRIKETIDE DELTA LACTONES | UNIVERSITE CATHOLIQUE DE LOUVAIN (BE) | 2006-09-06 | — | — | EP | disclosed |
| WO-2006083266-A1 | INHIBITORS OF BACTERIAL TYPE III PROTEIN SECRETION SYSTEMS | JANSSEN PHARMACEUTICA, N.V. (BE) | 2006-08-10 | — | — | WO | disclosed |
| US-7087622-B2 | Pyridone compounds as inhibitors of bacterial type III protein secreation systems | JANSSEN PHARMACEUTICA N.V. (BE) | 2006-08-08 | — | — | US | disclosed |
| US-20060149045-A1 | Steroid compounds with anti-tumor activity | UNIBIOSCREEN S.A. (BE) | 2006-07-06 | — | — | US | disclosed |
| EP-1675852-A1 | 7-AMINO ALKYLIDENYL-HETEROCYCLIC QUINOLONES AND NAPHTHYRIDONES | Janssen Pharmaceutica N.V. (BE) | 2006-07-05 | — | — | EP | disclosed |
| WO-2006064967-A1 | CELLULOSE ACYLATE FILM, PROCESS FOR PRODUCING CELLULOSE ACYLATE FILM, POLARIZING PLATE AND LIQUID CRYSTAL DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2006-06-22 | — | — | WO | disclosed |
| US-20060093759-A1 | Cellulose acylate film, process for producing cellulose acylate film, polarizing plate and liquid crystal display device | FUJI PHOTO FILM CO., LTD. (JP) | 2006-05-04 | — | — | US | disclosed |
| WO-2006047167-A2 | 9 ALKYL AND 9 ALKYLIDENYL 6-0 ALKYL-11, 12 CARBAMATE KETOLIDE ANTIMICROBIALS | JANSSEN PHARMACEUTICA, N.V. (BE) | 2006-05-04 | — | — | WO | disclosed |
| EP-1652926-A2 | Heterologous production of polyketides | Kosan Biosciences, Inc. (US) | 2006-05-03 | — | — | EP | disclosed |
| US-20060052359-A1 | 7-Amino alkylidenyl-heterocyclic quinolones and naphthyridones | JANSSEN PHARMACEUTICA, N.V. (BE) | 2006-03-09 | — | — | US | disclosed |
| US-6998256-B2 | Methods of obtaining epothilone D using crystallization and /or by the culture of cells in the presence of methyl oleate | KOSAN BIOSCIENCES, INC. (US) | 2006-02-14 | — | — | US | disclosed |
| US-20050282824-A1 | Substituted pyrimidines as inhibitors of bacterial type III protein secretion systems | LI XIAOBING | 2005-12-22 | — | — | US | disclosed |
| WO-2005121160-A2 | 11, 12 CYCLIC THIOCARBAMATE MACROLIDE ANTIBACTERIAL AGENTS | JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH & DEVELOPMENT (US) | 2005-12-22 | — | — | WO | disclosed |
| US-20050272784-A1 | Inhibitors of bacterial Type III protein secretion systems | LI XIAOBING | 2005-12-08 | — | — | US | disclosed |
| WO-2005113522-A1 | AZOLE CARBOXAMIDE INHIBITORS OF BACTERIAL TYPE III PROTEIN SECRETION SYSTEMS | JANSSEN PHARMACEUTICA, N.V. (BE) | 2005-12-01 | — | — | WO | disclosed |
| WO-2005113514-A2 | SUBSTITUTED PYRIMIDINES AS INHIBITORS OF BACTERIAL TYPE III PROTEIN SECRETION SYSTEMS | JANSSEN PHARMACEUTICA, N.V. (BE) | 2005-12-01 | — | — | WO | disclosed |
| WO-2005110988-A1 | PYRIDONE COMPOUNDS AS INHIBITORS OF BACTERIAL TYPE III PROTEIN SECRETION SYSTEMS | JANSSEN PHARMACEUTICA, N.V. (BE) | 2005-11-24 | — | — | WO | disclosed |
| WO-2005111017-A1 | TRIAZINE COMPOUNDS AS INHIBITORS OF BACTERIAL TYPE III PROTEIN SECRETION SYSTEMS | JANSSEN PHARMACEUTICA, N.V. (BE) | 2005-11-24 | — | — | WO | disclosed |
| US-20050256137-A1 | Pyridone compounds as inhibitors of bacterial type III protien secreation systems | JANSSEN PHARMACEUTICA, N.V. (BE) | 2005-11-17 | — | — | US | disclosed |
| US-20050250713-A1 | 11,12-Cyclic thiocarbamate macrolide antibacterial agents | ZHU BIN | 2005-11-10 | — | — | US | disclosed |
| US-20050250819-A1 | Inhibitors of bacterial type III protein secretion systems | JANSSEN PHARMACEUTICA, N.V. (BE) | 2005-11-10 | — | — | US | disclosed |
| US-20050250945-A1 | Triazine compounds as inhibitors of bacterial type III protein secretion systems | JANSSEN PHARMACEUTICA, N.V. (BE) | 2005-11-10 | — | — | US | disclosed |
| US-20050203257-A1 | Resin composition, and optical component, plastic lens and plastic film substrate utilizing the same | FUJI PHOTO FILM CO., LTD. (JP) | 2005-09-15 | — | — | US | disclosed |
| EP-1572715-A1 | STEROID COMPOUNDS WITH ANTI-TUMOR ACTIVITY | Unibioscreen S.A. (BE) | 2005-09-14 | — | — | EP | disclosed |
| WO-2005058934-A2 | GLYCOSYLATED STEROID DERIVATIVES WITH ANTI-MIGRATORY ACTIVITY | UNIBIOSCREEN S.A. (BE) | 2005-06-30 | — | — | WO | disclosed |
| WO-2005054267-A1 | GLYCOSYLATED TRIKETIDE DELTA LACTONES | UNIVERSITE CATHOLIQUE DE LOUVAIN (BE) | 2005-06-16 | — | — | WO | disclosed |
| US-6893859-B2 | Epothilone derivatives and methods for making and using the same | KOSAN BIOSCIENCES, INC. (US) | 2005-05-17 | — | — | US | disclosed |
| US-20050101588-A1 | 7-Amino alkylidenyl-heterocyclic quinolones and naphthyridones | GRANT EUGENE B III (US) | 2005-05-12 | — | — | US | disclosed |
| WO-2005033108-A1 | 7-AMINO ALKYLIDENYL-HETEROCYCLIC QUINOLONES AND NAPHTHYRIDONES | JANSSEN PHARMACEUTICA, N.V. (BE) | 2005-04-14 | — | — | WO | disclosed |
| US-6875576-B2 | Method for evaluating therapeutic efficacy | KOSAN BIOSCIENCES, INC. (US) | 2005-04-05 | — | — | US | disclosed |
| EP-1513856-A1 | 3-DESCLADINOSYL-6-O-CARBAMOYL AND 6-O-CARBONOYL MACROLIDE ANTIBACTERIAL AGENTS | JANSSEN PHARMACEUTICA N.V. (BE) | 2005-03-16 | — | — | EP | disclosed |
| US-20050038086-A1 | Epothilone derivatives and methods for making and using the same | ASHLEY GARY (US) | 2005-02-17 | — | — | US | disclosed |
| US-6825172-B2 | BACTERICIDES; AGAINST GRAMNEGATIVE, GRAMPOSITIVE BACTERIA | JANSSEN PHARMACEUTICA, NV (BE) | 2004-11-30 | — | — | US | disclosed |
| US-20040147461-A1 | Motilide compounds | ASHLEY GARY (US) | 2004-07-29 | — | — | US | disclosed |
| CN-1511192-A | Production of polyketides | �Ϻ���ͨ��ѧ | 2004-07-07 | — | — | CN | disclosed |
| WO-2004055039-A1 | STEROID COMPOUNDS WITH ANTI-TUMOR ACTIVITY | UNIBIOSCREEN S.A. (BE) | 2004-07-01 | — | — | WO | disclosed |
| EP-1430068-A1 | 6-O-CARBAMATE-11,12-LACTO-KETOLIDE ANTIMICROBIALS | Ortho-Mcneil Pharmaceutical, Inc. (US) | 2004-06-23 | — | — | EP | disclosed |
| US-6750205-B2 | NOVEL PROKINETIC AGENTS WITH SUPERIOR PHARMACOLOGICAL AND PHARMACOKINETIC PROPERTIES FOR THE TREATMENT OF GASTROINTESTINAL MOTILITY DISORDERS | KOSAN BIOSCIENCES, INC. | 2004-06-15 | — | — | US | disclosed |
| US-6713455-B2 | A BICYCLIC HETEROAROMATIC COMPOUND CONTAINING TWO KETO, TWO ESTER, A CARBAMATE GROUPS AND A METHYL, HYDROXY AND AMINE SUBSTITUTED OXYPYRAN RING; USEFUL ANTIBACTERIAL AGENT FOR TREATING PNEUMONIA, SKIN, SOFT TISSUE AND BONE INFECTIONS | ORTHO-MCNEIL PHARMACEUTICAL, INC. | 2004-03-30 | — | — | US | disclosed |
| US-20040018994-A1 | 3-Descladinosyl-6-O-carbamoyl and 6-O-carbonoyl macrolide antibacterial agents | JANSSEN PHARMACEUTICA N.V. (BE) | 2004-01-29 | — | — | US | disclosed |
| US-20040018598-A1 | Bio-intermediates for use in the chemical synthesis of polyketides | SANTI DANIEL (US) | 2004-01-29 | — | — | US | disclosed |
| WO-2003102010-A1 | 3-DESCLADINOSYL-6-O-CARBAMOYL AND 6-O-CARBONOYL MACROLIDE ANTIBACTERIAL AGENTS | JANSSEN PHARMACEUTICA N.V. (BE) | 2003-12-11 | — | — | WO | disclosed |
| EP-1365726-A2 | METHOD FOR EVALUATING THERAPEUTIC EFFICACY | Kosan Biosciences, Inc. (US) | 2003-12-03 | — | — | EP | disclosed |
| US-20030220271-A1 | Oxygen-bridged erythromycin derivatives for the treatment of gastrointestinal motility disorders such as GERD | PFIZER INC. | 2003-11-27 | — | — | US | disclosed |
| EP-1345953-A2 | KETOLIDE ANTIBACTERIALS | Ortho-Mcneil Pharmaceutical, Inc. (US) | 2003-09-24 | — | — | EP | disclosed |
| US-6624302-B2 | Culturing immunosuppressants, neurotrophic agents, and macrolactone antibiotics; side effect reduction | KOSAN BIOSCIENCES, INC. | 2003-09-23 | — | — | US | disclosed |
| EP-1343798-A1 | 6-O-CARBAMOYL KETOLIDE DERIVATIVES OF ERYTHROMYCIN USEFUL AS ANTIBACTERIALS | Ortho-Mcneil Pharmaceutical, Inc. (US) | 2003-09-17 | — | — | EP | disclosed |
| WO-2001083800-A9 | HETEROLOGOUS PRODUCTION OF POLYKETIDES | KOSAN BIOSCIENCES INC (US) | 2003-09-12 | — | — | WO | disclosed |
| US-6613747-B2 | Erythromycins to treat community-acquired pneumonia and upper and lower respiratory tract, skin and soft tissue, hospital-acquired lung, bone and joint infections; Staphyloccus; Enterococcus; Moraxella; Hemophilus; antibiotic resistance | ORTHO-MCNEIL PHARMACEUTICAL, INC. | 2003-09-02 | — | — | US | disclosed |
| EP-1337540-A2 | MOTILIDE COMPOUNDS | Kosan Biosciences, Inc. (US) | 2003-08-27 | — | — | EP | disclosed |
| US-20030144315-A1 | Novel polyketide derivatives | CHU DANIEL (US) | 2003-07-31 | — | — | US | disclosed |
| US-20030134883-A1 | 14-Methyl-epothilones | KOSAN BIOSCIENCES,INC. | 2003-07-17 | — | — | US | disclosed |
| US-6589968-B2 | Anticancer, antiproliferative and antiarthritic agents | KOSAN BIOSCIENCES, INC. | 2003-07-08 | — | — | US | disclosed |
| US-6590083-B1 | Compounds of given formula; erythromycin derivatives; useful in the treatment of bacterial and protozoal infections and conditions involving gastric motility | ORTHO-MCNEIL PHARMACEUTICAL, INC. | 2003-07-08 | — | — | US | disclosed |
| US-20030125267-A1 | 6-O-carbamate-11,12-lacto-ketolide antimicrobials | ORTHO-MCNEIL PHARMACEUTICAL, INC. | 2003-07-03 | — | — | US | disclosed |
| EP-1320611-A2 | HETEROLOGOUS PRODUCTION OF POLYKETIDES | Kosan Biosciences, Inc. (US) | 2003-06-25 | — | — | EP | disclosed |
| WO-2003045324-A2 | 14-METHYL-EPOTHILONES | KOSAN BIOSCIENCES, INC. (US) | 2003-06-05 | — | — | WO | disclosed |
| US-6569867-B2 | As drugs | KOSAN BIOSCIENCES, INC. | 2003-05-27 | — | — | US | disclosed |
| US-6562795-B2 | Gastrointestinal disorders | KOSAN BIOSCIENCES, INC. | 2003-05-13 | — | — | US | disclosed |
| EP-1307579-A2 | BIO-INTERMEDIATES FOR USE IN THE CHEMICAL SYNTHESIS OF POLYKETIDES | Kosan Biosciences, Inc. (US) | 2003-05-07 | — | — | EP | disclosed |
| US-20030073205-A1 | Production of polyketides | KOSAN BIOSCIENCES, INC. | 2003-04-17 | — | — | US | disclosed |
| WO-2003024986-A1 | 6-O-CARBAMATE-11,12-LACTO-KETOLIDE ANTIMICROBIALS | ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) | 2003-03-27 | — | — | WO | disclosed |
| US-20030045711-A1 | Epothilone derivatives and methods for making and using the same | KOSAN BIOSCIENCES, INC. | 2003-03-06 | — | — | US | disclosed |
| EP-1282626-A2 | POLYKETIDE DERIVATIVES | Kosan Biosciences, Inc. (US) | 2003-02-12 | — | — | EP | disclosed |
| US-20030023082-A1 | Epothilone derivatives and methods for making and using the same | KOSAN BIOSCIENCES, INC. | 2003-01-30 | — | — | US | disclosed |
| US-20030013663-A1 | 6-O-CARBAMOYL KETOLIDE ANTIBACTERIALS | ORTHO-MCNEIL PHARMACEUTICAL, INC. | 2003-01-16 | — | — | US | disclosed |
| US-6500815-B1 | BONE DISORDERS | AVENTIS PHARMA S.A. (FR) | 2002-12-31 | — | — | US | disclosed |
| US-20020192709-A1 | Method for evaluating therapeutic efficacy | PFIZER INC. | 2002-12-19 | — | — | US | disclosed |
| US-20020193361-A1 | Epothilone derivatives and methods for making and using the same | KOSAN BIOSCIENCES, INC. | 2002-12-19 | — | — | US | disclosed |
| US-20020183348-A1 | For use as drugs | CHU DANIEL (US) | 2002-12-05 | — | — | US | disclosed |
| US-6489314-B1 | DUE TO THE INCREASING INTEREST IN EPOTHILONES AS ANTI-CANCER AGENTS, NOVEL DERIVATIVES OF THESE COMPOUNDS ARE NEEDED AND DESIRED TO MORE FULLY DEVELOP THEIR THERAPEUTIC POTENTIAL | KOSAN BIOSCIENCES, INC. | 2002-12-03 | — | — | US | disclosed |
| EP-1255763-A2 | MOTILIDE COMPOUNDS | Kosan Biosciences, Inc. (US) | 2002-11-13 | — | — | EP | disclosed |
| US-6472372-B1 | 6-O-Carbamoyl ketolide antibacterials | ORTHO-MCNEIL PHARMACEUTICALS, INC. | 2002-10-29 | — | — | US | disclosed |
| US-20020156110-A1 | Epothilone compounds and methods for making and using the same | KOSAN BIOSCIENCES, INC. | 2002-10-24 | — | — | US | disclosed |
| WO-2002080846-A2 | EPOTHILONE DERIVATIVES AND METHODS FOR MAKING AND USING THE SAME | KOSAN BIOSCIENCES, INC. (US) | 2002-10-17 | — | — | WO | disclosed |
| US-20020128213-A1 | Sixteen-membered macrolide compounds | KOSAN BIOSCIENCES, INC. | 2002-09-12 | — | — | US | disclosed |
| US-20020115620-A1 | 6-0-carbamoyl ketolide antibacterials | ORTHO-MCNEIL PHARMACEUTICAL, INC. | 2002-08-22 | — | — | US | disclosed |
| WO-2002064092-A2 | METHOD FOR EVALUATING THERAPEUTIC EFFICACY | KOSAN BIOSCIENCES, INC. (US) | 2002-08-22 | — | — | WO | disclosed |
| US-20020111317-A1 | Sixteen-membered macrolide compounds | KOSAN BIOSCIENCES, INC. | 2002-08-15 | — | — | US | disclosed |
| US-20020094962-A1 | Motilide compounds | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2002-07-18 | — | — | US | disclosed |
| WO-2002051855-A2 | MOTILIDE COMPOUNDS | KOSAN BIOSCIENCES, INC. (US) | 2002-07-04 | — | — | WO | disclosed |
| WO-2002046204-A1 | 6-0-CARBAMOYL KETOLIDE DERIVATIVES OF ERYTHROMYCIN USEFUL AS ANTIBACTERIALS | ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) | 2002-06-13 | — | — | WO | disclosed |
| US-20020065295-A1 | Novel polyketide derivatives | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2002-05-30 | — | — | US | disclosed |
| US-20020052028-A1 | Bio-intermediates for use in the chemical synthesis of polyketides | KOSAN BIOSCIENCES, INC. | 2002-05-02 | — | — | US | disclosed |
| WO-2002032918-A2 | KETOLIDE ANTIBACTERIALS | ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) | 2002-04-25 | — | — | WO | disclosed |
| WO-2002032916-A2 | SIXTEEN-MEMBERED MACROLIDE COMPOUNDS | KOSAN BIOSCIENCES, INC. (US) | 2002-04-25 | — | — | WO | disclosed |
| US-20020045609-A1 | Epothilone derivatives and methods for making and using the same | KOSAN BIOSCIENCES, INC. | 2002-04-18 | — | — | US | disclosed |
| US-20020025936-A1 | Motilide compounds | PFIZER INC. | 2002-02-28 | — | — | US | disclosed |
| WO-2002012534-A2 | BIO-INTERMEDIATES FOR USE IN THE CHEMICAL SYNTHESIS OF POLYKETIDES | KOSAN BIOSCIENCES, INC. (US) | 2002-02-14 | — | — | WO | disclosed |
| US-6339082-B1 | FOR THERAPY OF DISEASES CAUSED BY LOSS OF BONE MATRIX | AVENTIS PHARMA S.A. (FR) | 2002-01-15 | — | — | US | disclosed |
| WO-2001092255-A2 | EPOTHILONE DERIVATIVES AND METHODS FOR MAKING AND USING THE SAME | KOSAN BIOSCIENCES, INC. (US) | 2001-12-06 | — | — | WO | disclosed |
| WO-2001087884-A2 | POLYKETIDE DERIVATIVES | KOSAN BIOSCIENCES, INC. (US) | 2001-11-22 | — | — | WO | disclosed |
| WO-2001083800-A2 | HETEROLOGOUS PRODUCTION OF POLYKETIDES | KOSAN BIOSCIENCES, INC. (US) | 2001-11-08 | — | — | WO | disclosed |
| WO-2001060833-A2 | MOTILIDE COMPOUNDS | KOSAN BIOSCIENCES, INC. (US) | 2001-08-23 | — | — | WO | disclosed |
| US-6277845-B1 | BONE DISEASE PROPHYLACTICS, ANTIMETASTASIS AGENTS | AVENTIS PHARMA S.A. (FR) | 2001-08-21 | — | — | US | disclosed |
| US-5880280-A | Aryl, alkyl, alkenyl and alkynylmacrolides having immunosuppressive activity | MERCK & CO., INC. (US) | 1999-03-09 | — | — | US | disclosed |
| EP-0766685-A4 | ARYL, ALKYL, ALKENYL, AND ALKYNYLMACROLIDES | MERCK & CO INC (US) | 1997-07-16 | — | — | EP | disclosed |
| EP-0767791-A1 | ARYL, ALKYL, ALKENYL AND ALKYNYLMACROLIDES HAVING IMMUNOSUPPRESSIVE ACTIVITY | MERCK & CO. INC. (US) | 1997-04-16 | — | — | EP | disclosed |
| EP-0766685-A1 | ARYL, ALKYL, ALKENYL, AND ALKYNYLMACROLIDES | MERCK & CO. INC. (US) | 1997-04-09 | — | — | EP | disclosed |
| EP-0532088-B1 | O-Heteroaryl, O-alkylheteroaryl, O-alkenylheteroaryl and O-alkynylheteroaryl macrolides | MERCK & CO INC (US) | 1996-12-04 | — | — | EP | disclosed |
| US-5550233-A | AUTOIMMUNE DISEASES; PREVENTION OF TRANSPLANT REJECTION | MERCK & CO., INC. (US) | 1996-08-27 | — | — | US | disclosed |
| US-5545734-A | Aryl and heteroaryl macrolides having immunosuppressive activity | MERCK & CO., INC. (US) | 1996-08-13 | — | — | US | disclosed |
| WO-1995035299-A1 | ARYL, ALKYL, ALKENYL AND ALKYNYLMACROLIDES HAVING IMMUNOSUPPRESSIVE ACTIVITY | MERCK & CO., INC. (US) | 1995-12-28 | — | — | WO | disclosed |
| WO-1995034568-A1 | ARYL, ALKYL, ALKENYL, AND ALKYNYLMACROLIDES | MERCK & CO., INC. (US) | 1995-12-21 | — | — | WO | disclosed |
| US-5349061-A | O-heteroaryl, O-alkylheteroaryl, O-alkenylheteroaryl and O-alkynylheteroarylmacrolides having immunosuppressive activity | MERCK & CO., INC. (US) | 1994-09-20 | — | — | US | disclosed |
| US-5284877-A | Autoimmune diseases; prevention of transplant rejection; antiinflammatory agents; skin disorders; antiobiotics FK-506 | MERCK & CO., INC. (US) | 1994-02-08 | — | — | US | disclosed |
| US-5284840-A | Autoimmune diseases; prevention of tranplant rejection; antiinflammatory agents; skin disorders; antiobiotics FK-506 | MERCK & CO., INC. (US) | 1994-02-08 | — | — | US | disclosed |
| US-5252732-A | D-heteroaryl, O-alkylheteroaryl, O-alkenylheteroaryl and O-alkynylheteroarylmacrolides having immunosuppressive activity | MERCK & CO., INC. (US) | 1993-10-12 | — | — | US | disclosed |
| WO-1993005058-A1 | O-HETEROARYL, O-ALKYLHETEROARYL, O-ALKENYLHETEROARYL AND O-ALKYNYLHETEROARYLMACROLIDES | MERCK & CO., INC. (US) | 1993-03-18 | — | — | WO | disclosed |
| EP-0532088-A1 | O-Heteroaryl, O-alkylheteroaryl, O-alkenylheteroaryl and O-alkynylheteroaryl macrolides | MERCK & CO. INC. (US) | 1993-03-17 | — | — | EP | disclosed |
| EP-0532088-A1 | O-Heteroaryl, O-alkylheteroaryl, O-alkenylheteroaryl and O-alkynylheteroaryl macrolides | MERCK & CO. INC. (US) | 1993-03-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (50 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090159857-A1 | OPTICAL FILM AND PHASE DIFFERENCE PLATE, AND LIQUID CRYSTAL COMPOUND | NOM1, CRYZ, CNN2 | MAPK1 830/4885L3MBTL1 1383/4885ELANE 2431/4885 |
| US-20090202921-A1 | OPTICAL RECORDING COMPOSITION AND HOLOGRAPHIC RECORDING MEDIUM | CHRNA6, NR2E3, NR4A1 | MAPK1 2035/4885L3MBTL1 3535/4885ELANE 4702/4885 |
| US-20090085008-A1 | Cellulose compound composition and cellulose compound film | C1S, C1R, C5 | MAPK1 1041/4885L3MBTL1 933/4885ELANE 1812/4885 |
| US-10005804-B2 | TC-PTP inhibitors as APC activators for immunotherapy | PTPRCAP, PTPRC, PTPA | MAPK1 2133/4885L3MBTL1 4450/4885ELANE 1662/4885 |
| US-20060052359-A1 | 7-Amino alkylidenyl-heterocyclic quinolones and naphthyridones | NQO2, NQO1, REN | MAPK1 2562/4885L3MBTL1 4030/4885ELANE 1022/4885 |
| US-20070123473-A1 | Glycosylated steroid derivatives with anti-migratory activity | NR5A1, NR3C2, MIF | MAPK1 1202/4885L3MBTL1 4485/4885ELANE 230/4885 |
| US-20110237804-A1 | COMPOUND HAVING A TRIPTYCENE MOIETY | CHRM1, H1-2, H1-0 | MAPK1 2531/4885L3MBTL1 1441/4885ELANE 1697/4885 |
| US-20070092954-A1 | Production of polyketides | DHPS, MRPL21, FDFT1 | MAPK1 2300/4885L3MBTL1 3063/4885ELANE 3649/4885 |
| US-20030073205-A1 | Production of polyketides | DHPS, MRPL21, FDFT1 | MAPK1 2300/4885L3MBTL1 3063/4885ELANE 3649/4885 |
| US-20020045609-A1 | Epothilone derivatives and methods for making and using the same | DHPS, MCL1, HCCS | MAPK1 2725/4885L3MBTL1 546/4885ELANE 593/4885 |
| US-20050250713-A1 | 11,12-Cyclic thiocarbamate macrolide antibacterial agents | MRPL21, TTC14, MRPL12 | MAPK1 3782/4885L3MBTL1 2889/4885ELANE 942/4885 |
| US-20050272784-A1 | Inhibitors of bacterial Type III protein secretion systems | GBA3, PSMB3, SEC61B | MAPK1 1936/4885L3MBTL1 2721/4885ELANE 117/4885 |
| US-20150338563-A1 | RESIN COMPOSITION, TRIAZOLE COMPOUND, OPTICAL FILM, POLARIZING PLATE, OPTICAL LENS, CIRCULARLY POLARIZING PLATE AND IMAGE DISPLAY DEVICE | HRH3, HELZ, NBAS | MAPK1 4036/4885L3MBTL1 4442/4885ELANE 2611/4885 |
| US-20050101588-A1 | 7-Amino alkylidenyl-heterocyclic quinolones and naphthyridones | NQO2, NQO1, REN | MAPK1 2562/4885L3MBTL1 4030/4885ELANE 1022/4885 |
| US-20030045711-A1 | Epothilone derivatives and methods for making and using the same | EPOR, SRD5A1, SRD5A2 | MAPK1 1636/4885L3MBTL1 1769/4885ELANE 523/4885 |
| US-20060149045-A1 | Steroid compounds with anti-tumor activity | CYP17A1, HSD17B7, NR5A1 | MAPK1 2987/4885L3MBTL1 4883/4885ELANE 1479/4885 |
| US-20100144846-A1 | Oligoribonucleotides and uses thereof | TLR3, DCLRE1B, TLR9 | MAPK1 4621/4885L3MBTL1 262/4885ELANE 3472/4885 |
| US-20030125267-A1 | 6-O-carbamate-11,12-lacto-ketolide antimicrobials | ARG1, LPO, Q6ZSR9 | MAPK1 2729/4885L3MBTL1 67/4885ELANE 619/4885 |
| US-20020094962-A1 | Motilide compounds | MRPS18B, NAT10, MRPS22 | MAPK1 2600/4885L3MBTL1 213/4885ELANE 1716/4885 |
| US-20030134883-A1 | 14-Methyl-epothilones | DNMT1, TET1, MYC | MAPK1 1579/4885L3MBTL1 728/4885ELANE 1124/4885 |
| US-10012777-B2 | Resin composition | NBAS, WDR5, HRH3 | MAPK1 4440/4885L3MBTL1 4505/4885ELANE 2191/4885 |
| US-20090080074-A1 | POLYMER FILM, POLARIZING PLATE PROTECTIVE FILM, POLARIZING PLATE AND LIQUID CRYSTAL DISPLAY DEVICE | RPA3, RTF1, RPA1 | MAPK1 1655/4885L3MBTL1 1484/4885ELANE 2359/4885 |
| US-20180203175-A1 | TRIAZOLE COMPOUND | H1-10, TTI2, H1-2 | MAPK1 2013/4885L3MBTL1 1165/4885ELANE 1191/4885 |
| US-20020111317-A1 | Sixteen-membered macrolide compounds | NOP2, NSUN3, MRPS23 | MAPK1 4682/4885L3MBTL1 1886/4885ELANE 1893/4885 |
| US-20040018994-A1 | 3-Descladinosyl-6-O-carbamoyl and 6-O-carbonoyl macrolide antibacterial agents | CHCHD6, MRPL21, MRPS18B | MAPK1 2932/4885L3MBTL1 1042/4885ELANE 1128/4885 |
| US-20070111952-A1 | Glycosylated triketide delta lactones | AGL, AKR1C3, AKR1C4 | MAPK1 1598/4885L3MBTL1 295/4885ELANE 3800/4885 |
| US-20030013663-A1 | 6-O-CARBAMOYL KETOLIDE ANTIBACTERIALS | Q6ZSR9, KDM4E, HK1 | MAPK1 3014/4885L3MBTL1 423/4885ELANE 1332/4885 |
| US-10174132-B2 | Heparan sulfate synthesis | HPSE, STT3B, DDOST | MAPK1 3660/4885L3MBTL1 3217/4885ELANE 2471/4885 |
| US-20090018305-A1 | TRIAZINE DERIVATIVE, LIQUID CRYSTAL COMPOSITION, ANISOTROPIC MATERIAL, AND LIQUID CRYSTAL DISPLAY DEVICE USING THE SAME | H1-0, H1-2, CHRM1 | MAPK1 1934/4885L3MBTL1 379/4885ELANE 1226/4885 |
| US-20170037159-A1 | POLYMERIZABLE COMPOUNDS, COMPOSITIONS, POLYMERS, OPTICALLY ANISOTROPIC ARTICLES, LIQUID CRYSTAL DISPLAY DEVICES AND ORGANIC EL DEVICES | LASP1, ILK, LAS1L | MAPK1 1943/4885L3MBTL1 1288/4885ELANE 778/4885 |
| US-20050250945-A1 | Triazine compounds as inhibitors of bacterial type III protein secretion systems | PSMB5, GTF3C3, GTF3C5 | MAPK1 2448/4885L3MBTL1 3124/4885ELANE 333/4885 |
| US-20090054658-A1 | Liquid Crystal Compound, Liquid Crystal Composition, Thin Film and Liquid Crystal Display | NR0B1, NR0B2, NAP1L1 | MAPK1 2426/4885L3MBTL1 1180/4885ELANE 1794/4885 |
| US-20040018598-A1 | Bio-intermediates for use in the chemical synthesis of polyketides | DHPS, FDFT1, COASY | MAPK1 3207/4885L3MBTL1 1483/4885ELANE 3103/4885 |
| US-20020183348-A1 | For use as drugs | HSD17B14, CYP3A4, CYP3A5 | MAPK1 4572/4885L3MBTL1 2340/4885ELANE 520/4885 |
| US-20050250819-A1 | Inhibitors of bacterial type III protein secretion systems | PSMB3, GBA3, PSMG3 | MAPK1 2102/4885L3MBTL1 2839/4885ELANE 181/4885 |
| US-20020156110-A1 | Epothilone compounds and methods for making and using the same | HCCS, DHPS, MCL1 | MAPK1 2083/4885L3MBTL1 1012/4885ELANE 217/4885 |
| US-20050282824-A1 | Substituted pyrimidines as inhibitors of bacterial type III protein secretion systems | UMPS, NUDT14, NUDT5 | MAPK1 2811/4885L3MBTL1 3550/4885ELANE 1106/4885 |
| US-20180072763-A1 | TC-PTP INHIBITORS AS APC ACTIVATORS FOR IMMUNOTHERAPY | PTPRCAP, PTPRC, PTPA | MAPK1 2133/4885L3MBTL1 4450/4885ELANE 1662/4885 |
| US-20020025936-A1 | Motilide compounds | MLNR, CCR10, PTCD3 | MAPK1 1928/4885L3MBTL1 544/4885ELANE 1359/4885 |
| US-20090189120-A1 | COMPOUND, LIQUID CRYSTAL COMPOSITION, AND ANISOTROPIC MATERIAL | CCNA2, CCNA1, CCNB2 | MAPK1 2063/4885L3MBTL1 1426/4885ELANE 1174/4885 |
| US-20030220271-A1 | Oxygen-bridged erythromycin derivatives for the treatment of gastrointestinal motility disorders such as GERD | HRH2, CBR3, CBR1 | MAPK1 1632/4885L3MBTL1 1547/4885ELANE 1888/4885 |
| US-20160060365-A1 | HEPARAN SULFATE SYNTHESIS | HPSE, STT3B, DDOST | MAPK1 3660/4885L3MBTL1 3217/4885ELANE 2471/4885 |
| US-20150247963-A1 | OPTICAL FILM, CIRCULARLY POLARIZING PLATE, AND IMAGE DISPLAY DEVICE | SUN2, HTR3D, CRY1 | MAPK1 3391/4885L3MBTL1 1265/4885ELANE 3641/4885 |
| US-20060241076-A1 | Modified oligoribonucleotide analogs with enhanced immunostimulatory activity | TLR3, TLR8, TLR9 | MAPK1 3670/4885L3MBTL1 776/4885ELANE 1019/4885 |
| US-20140051603-A1 | COMPOUNDS AND METHODS FOR CHEMICAL AND CHEMO-ENZYMATIC SYNTHESIS OF COMPLEX GLYCANS | ENGASE, FUT6, GALE | MAPK1 3868/4885L3MBTL1 4035/4885ELANE 1547/4885 |
| US-20090156577-A1 | 7-AMINO ALKYLIDENYL-HETEROCYCLIC QUINOLONES AND NAPHTHYRIDONES | NQO2, QRFPR, NQO1 | MAPK1 2916/4885L3MBTL1 3971/4885ELANE 747/4885 |
| US-20020128213-A1 | Sixteen-membered macrolide compounds | NOP2, NSUN3, MRPS23 | MAPK1 4682/4885L3MBTL1 1886/4885ELANE 1893/4885 |
| US-20030144315-A1 | Novel polyketide derivatives | HSD17B14, RIOX2, MRPL21 | MAPK1 4465/4885L3MBTL1 1481/4885ELANE 2033/4885 |
| US-20070281343-A9 | Recombinant Myxococcus host cells used to produce polyketides, including epothilone and epothilone analogs; agriculture, chemistry, medicinal chemistry, medicine, molecular biology, and pharmacology | MRPL21, SQLE, DHPS | MAPK1 1503/4885L3MBTL1 3019/4885ELANE 4192/4885 |
| US-20110244025-A1 | MODIFIED OLIGORIBONUCLEOTIDE ANALOGS WITH ENHANCED IMMUNOSTIMULATORY ACTIVITY | TLR3, TLR9, TLR8 | MAPK1 3694/4885L3MBTL1 772/4885ELANE 1003/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.